Genoscience Pharma Is Innovating to Change the Cancer Landscape

To design, develop and commercialize novel therapies intended to improve patients' quality of life and resolve serious unmet medical healthcare needs

Genoscience Approach

One of the fundamental challenges in cancer treatment is cancer resistance and relapse. A reason for this acquired resistance may be the presence of small minority of cells in the tumor called cancer stem cells (CSC). Most current anti-cancer chemotherapeutics primarily target either differentiated or proliferating cancer cells, and concretively, will not be effective against CSCs.

Discover

Pipeline

With more than 780,000 new cases diagnosed every year, liver cancer is the fifth most common cancer worldwide. Almost 400,000 new cases are diagnosed annually in China, Japan and South Korea, 52,000 in the EU and about 30,000 in the United States. Men are significantly more affected overall than women.
Liver cancer causes death more often than many other tumors, and patients are usually diagnosed with late-stage disease.

Discover

News

News
22 May 2018

Genoscience Pharma extends its first clinical trial of GN561 in patients with advanced liver cancers to France

Enrollment is open for patients with intrahepatic cholangiocarcinoma and hepatocarcinoma at Croix-Rousse Hospital in Lyon…
Read More
News
05 April 2018

Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer at the Jules Bordet Institute, Brussels

First-in-class small molecule with a new mechanism of action; two-year IND international clinical trial involving…
Read More
News
11 January 2018

Clinical significance of high expression of a specific solute carrier transporter in HCC.

Abstract #202913 Clinical significance of high expression of a specific solute carrier transporter in HCC.…
Read More

Events

Events
11-15 April 2018

The EASL-International Liver Congress Meeting 2018 – Paris, FRANCE

Genoscience Pharma was present during the EASL-ILC Meeting 2018, Paris, FRANCE
Read More
Events
20-24 October 2017

The Liver Meeting 2017- AASLD – Washigton, D.C., USA

Genoscience Pharma will be present during the Liver Meeting 2017 - AASLD  A poster will…
Read More
Events
3-7 June 2016

The American Society of Clinical Oncology Annual Meeting 2016

Even the all-powerful Pointing has no control about the blind texts it is an almost
Read More

Bringing a new hope to cancer patients by providing innovative approaches for a better care

Philippe Halfon, CEO of Genoscience Pharma